|
MOBKL1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.94010412974444E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.27249988324252E-10 |
| Normal-vs-Stage2 |
4.49390000000216E-05 |
| Normal-vs-Stage3 |
4.24699999945766E-07 |
| Normal-vs-Stage4 |
4.70529948337628E-10 |
| Stage1-vs-Stage2 |
5.908200E-01 |
| Stage1-vs-Stage3 |
6.210600E-01 |
| Stage1-vs-Stage4 |
3.074500E-02 |
| Stage2-vs-Stage3 |
4.678800E-01 |
| Stage2-vs-Stage4 |
3.482400E-02 |
| Stage3-vs-Stage4 |
1.491240E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.5388003638559E-10 |
| Normal-vs-AfricanAmerican |
6.637700E-03 |
| Normal-vs-Asian |
1.88609999951517E-07 |
| Caucasian-vs-AfricanAmerican |
3.155200E-01 |
| Caucasian-vs-Asian |
5.576200E-01 |
| AfricanAmerican-vs-Asian |
2.156400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.20659999558859E-08 |
| Normal-vs-Female |
1.6056000973208E-10 |
| Male-vs-Female |
3.540200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.35390001829461E-09 |
| Normal-vs-Age(41-60Yrs) |
4.51560000502838E-09 |
| Normal-vs-Age(61-80Yrs) |
2.81259999734829E-08 |
| Normal-vs-Age(81-100Yrs) |
2.839900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.231000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.949600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.953000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.053800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.463400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.165400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.048220E-02 |
| Classical-VS-Follicular |
5.209200E-01 |
| Classical-VS-Other |
8.547800E-01 |
| Classical-VS-Normal |
5.56589996314472E-09 |
| Tall-VS-Follicular |
1.561880E-02 |
| Tall-VS-Other |
1.442820E-01 |
| Tall-VS-Normal |
2.70220001929999E-09 |
| Follicular-VS-Other |
9.766400E-01 |
| Follicular-VS-Normal |
2.55660000003655E-06 |
| Other-VS-Normal |
4.229900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.30560004211134E-09 |
| Normal-vs-N1 |
5.4050000031225E-08 |
| N0-vs-N1 |
3.049000E-01 |
|
|
